You are now leaving Xalutestudy.com and going to a trusted partner website.
A Clinical Study for Men With Advanced Prostate Cancer
The study is testing a new investigational immunotherapy called Xaluritamig for castration-resistant prostate cancer.
Participants will be in the study for about 5 years.